Retropharyngeal lymph node metastasis in nasopharyngeal carcinoma detected by magnetic resonance imaging: Prognostic value and staging categories

Cancer

Volumn 113, Issue 2, 2008, Pages 347-354

  Tang, Linglong ^a,b   Li, Li ^a,b   Mao, Yanping ^a,b   Liu, Lizhi ^a,b   Liang, Shaobo ^a,b   Chen, Yong ^a,b   Sun, Ying ^a,b   Liao, Xinbiao ^a,b   Tian, Li ^a,b   Lin, Aihua ^b   Liu, Mengzhong ^a,b   Ma, Jun ^a,b  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

Magnetic resonance imaging; Nasopharyngeal carcinoma; Prognostic value; Retropharyngeal lymph node; Staging

Indexed keywords

GADOLINIUM PENTETATE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CHILD; DISEASE FREE SURVIVAL; DISTANT METASTASIS; FEMALE; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NASOPHARYNX CARCINOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROGNOSIS; TUMOR LOCALIZATION;

ADOLESCENT; ADULT; AGED; CHILD; FEMALE; HUMANS; LYMPHATIC METASTASIS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NEOPLASM STAGING; PROGNOSIS; SURVIVAL RATE;

EID: 48249115515     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.23555     Document Type: Article

References (28)

1. Parkin DM, Whelan SL, Ferlay J, Raymond L, Young J, eds. Cancer incidence in 5 continents. Vol 7. Oral cavity and pharynx. Lyon, France: IARC; 1997: 814-815.
2. Fandi A, Altun M, Azli N, et al. Nasopharyngeal cancer: epidemiology, staging, and treatment. Semin Oncol. 1994;21: 382-397.
3. Sham JST, Choy D, Wei WI. Nasopharyngeal carcinoma: orderly neck node spread. Int J Radiat Oncol Biol Phys. 1990;19:929-933.
4. Lam WW, Chan YL, Leung SF, et al. Retropharyngeal lymphadenopathy in nasopharyngeal carcinoma. Head Neck. 1997; 19:176-181.
5. Pharynx (including base of tongue, soft palate and uvula). In: Greene FL, Page DL, Fleming ID, et al., eds. AJCC Cancer Staging Manual. 6th ed. New York: Springer-Verlag, 2002:48-60.
6. Lee AW, Au JS, Teo PM, et al. Staging of nasopharyngeal carcinoma: suggestions for improving the current UICC/ AJCC staging system. Clin Oncol. 2004;16:269-276.
7. Chua DT, Sham JS, Kwong DL, et al. Retrophayrngeal lymphadenopathy in patients with nasopharyngeal carcinoma. Cancer. 1997;79:869-877.
8. Ma J, Liu L, Tang L, et al. Retropharyngeal lymphadenopathy in nasopharyngeal carcinoma: prognostic value and staging categories. Clin Cancer Res. 2007;13:1445-1452.
9. Mancuso AA, Harnsberger HR, Muraki AS, et al. Computed tomography of cervical and retropharyngeal lymph nodes: normal anatomy, variants of normal, and applications in staging head and neck cancer. Part II. Pathol Radiol. 1983;148:715-723.
10. Ng SH, Chang TC, Ko SF, et al. Nasopharyngeal carcinoma: MRI and CT assessment. Neuroradiology. 1997;39:741-746.
11. King AD, Teo P, Lam WW, et al. Paranasopharyngeal space involvement in nasopharyngeal cancer: detection by CT and MRI. Clin Oncol (R Coll Radiol). 2000;12:397-402.
12. van Hasselt CA. Nasopharyngeal Carcinoma. 2nd ed. Lam WW, King AD. Imaging. Hong Kong: The Chinese University Press; 1999:127-160.
13. Van den Brekel MW, Stel HV, Castelijns JA, et al. Cervical lymph node metastasis: assessment of radiologic criteria. Radiology. 1990;177:379-384.
14. Zhao C, Han F, Lu LX, et al. Intensity modulated radiotherapy for local-regional advanced nasopharyngeal carcinoma. Ai Zheng. 2004;23 (Suppl 11):1532-1537.
15. Wei L, Xiao-Wu D, Tai-Xiang L. Dosimetric evaluation for 3 dimensional radiotherapy plans for patients with early nasopharyngeal carcinoma. Ai Zheng. 2004;23:605-608.
16. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
17. Cox DR. Regression models and life tables. J R Stat Soc B. 1972;34:187-220.
18. Ma J, Mai HQ, Hong MH, et al. Is the 1997 AJCC staging system for nasopharyngeal carcinoma prognostically useful for Chinese patient population? Int J Radiat Oncol Biol Phys. 2001;50:1181-1189.
19. Heng DM, Wee J, Fong KW, et al. Prognostic factors in 677 patients in Singapore with nondisseminated nasopharyngeal carcinoma. Cancer. 1999;86:1912-1920.
20. Baujat B, Audry H, Bourhis J, et al. Chemotherapy in locally advanced nasopharyngeal carcinoma: an individual patient data meta-analysis of 8 randomized trials and 1753 patients. Int J Radiat Oncol Biol Phys. 2006;64:47-56.
21. Lee AW, Sze WM, Au JS, et al. Treatment results for nasopharyngeal carcinoma in the modern era: the Hong Kong experience. Int J Radiat Oncol Biol Phys. 2005;61:1107-1116.
22. Xiao GL, Gao L, Xu GZ. Prognostic influence of parapharyngeal space involvement in nasopharyngeal carcinoma, Int J Radiat Oncol Biol Phys. 2002;52:957-963.
23. Som PM. Detection of metastasis in cervical lymph nodes: CT and MR criteria and differential diagnosis. Am J Radiol. 1992;158:961-969.
24. Morrissey DD, Talbot JM, Cohen JI, et al. Accuracy of computed tomography in determining the presence or absence of metastatic retropharyngeal adenopathy. Arch Otolaryngol Head Neck Surg. 2000;126:1478-1481.
25. Dubrulle F, Souillard R, Hermans R. Extension patterns of nasopharyngeal carcinoma. Eur Radiol. 2007;17:2622-2630.
26. Groome PA, Schulze K, Boysen M, et al. A comparison of published head and neck stage groupings in carcinomas of the oral cavity. Head Neck. 2001;23:613-624.
27. Lee N, Xia P, Quivey JM, et al. Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience. Int J Radiat Oncol Biol Phys. 2002;53:12-22.
28. Kam MK, Teo PM, Chau RM, et al. Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience. Int J Radiat Oncol Biol Phys. 2004;60:1440-1450.